Sabrina A.J. Veld

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

Renske M.T. ten Ham, Anke M. Hövels, Jarno Hoekman et al. · Cytotherapy · 2020 · 60 citations · Full text

Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines

Pauline Meij, Inge Jedema, Maarten L. Zandvliet et al. · Journal of Immunotherapy · 2012 · 52 citations

Rapid Generation of Marker-Free P. falciparum Fluorescent Reporter Lines Using Modified CRISPR/Cas9 Constructs and Selection Protocol

Catherin Marin Mogollon, Fiona J. A. van Pul, Takashi Imai et al. · PLoS ONE · 2016 · 47 citations · Full text

Engineering, Genetics, Malaria +18

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

Peter van Balen, Inge Jedema, Marleen M. van Loenen et al. · Frontiers in Immunology · 2020 · 38 citations · Full text

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II

Peter van Balen, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs et al. · Frontiers in Immunology · 2018 · 30 citations · Full text